Safety and efficacy of a wireless pulmonary artery pressure sensor: primary endpoint results of the SIRONA 2 clinical trial

AIMS: Implantable pulmonary artery pressure (PAP) sensors have been shown to reduce heart failure hospitalizations (HFH) in selected patients. The goal of this study was to evaluate the safety and efficacy of a novel wireless PAP monitoring system in patients with heart failure (HF). METHODS AND RES...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharif, Faisal, Rosenkranz, Stephen, Bartunek, Jozef, Kempf, Tibor, Assmus, Birgit, Mahon, Niall G., Mullens, Wilfried
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715805/
https://www.ncbi.nlm.nih.gov/pubmed/35686479
http://dx.doi.org/10.1002/ehf2.14006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715805/
https://www.ncbi.nlm.nih.gov/pubmed/35686479
http://dx.doi.org/10.1002/ehf2.14006

Ejemplares similares